BTIG Reiterates Buy Rating on DexCom (DXCM)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/2/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- Equities rebound to close higher as surging Treasury yields recede
- onsemi cuts Synaptics deal price to $5.7B after rival bid
- Twilio, Vylor set to join S&P 500 as index reshuffles members
- Wells Fargo names 13 stocks as overweight tactical ideas
DexCom (DXCM) PT Raised to $86 at Bernstein SocGen Group
October 25, 2024 6:25 AM EDTBernstein SocGen Group analyst Lee Hambright raised the price target on DexCom (NASDAQ: DXCM) to $86.00 (from $82.00) while maintaining a Market Perform rating.
The analyst comments "In-line quarter. Revenue grew 3% organic, landing at the high-end of the reduced guidance range that DXCM set on the Q2 call (1% to 3%). U.S. sales declined -2% organic,... More
After-hours movers: Capri Holdings, Skechers, DexCom, Western Digital and more
October 24, 2024 4:42 PM EDTAfter-Hours Stock Movers:
Capri Holdings (NYSE: CPRI) shares fell 48% after a judge blocked its deal to merge with Tapestry (NYSE: TPR), a victory for the FTC. Tapestry shares gained.
DexCom (NASDAQ:... More
DexCom Q3 earnings beat estimates, but stock tumbles 16% on weak growth
October 24, 2024 4:16 PM EDTDexCom (NASDAQ: DXCM) reported third-quarter earnings that surpassed analyst expectations, but the company's stock plummeted 16% as revenue growth slowed significantly.
The continuous glucose monitoring systems maker posted adjusted earnings per share of $0.45, beating the analyst consensus of $0.43. Revenue for the quarter came in at... More
DexCom (DXCM) Tops Q3 EPS by 2c, Maintains Guidance
October 24, 2024 4:04 PM EDTDexCom (NASDAQ: DXCM) reported Q3 EPS of $0.45, $0.02 better than the analyst estimate of $0.43. Revenue for the quarter came in at $994.2 million versus the consensus estimate of $990.44 million.
GUIDANCE:
DexCom sees FY2024 revenue of $4-4.05 billion, versus the consensus of $4.01... More
